Intas Pharmaceuticals Limited Doxorubicin Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Doxorubicin Export Records India — #6 Exporter, 393 Shipments, $1.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Doxorubicin

India Pharmaceutical Trade Intelligence

$67.3M310 Suppliers136 CountriesHS 30049046

ExportsIndia → UNITED STATES39.4%India → CANADA18.9%

ImportsAUSTRALIA → India$16.6M BELGIUM → India$508.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: TARO PHARMACEUTICALS

Intas Pharmaceuticals Limited — Doxorubicin Exporter #6 | $1.8M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Doxorubicin Exporter Profile

Indian Pharmaceutical Exporter · #6 for Doxorubicin · $1.8M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #6 Indian exporter of Doxorubicin with $1.8M in export value and 393 verified shipments. Intas Pharmaceuticals Limited holds a 2.7% market share in Doxorubicin exports across 16 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Doxorubicin Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Doxorubicin export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Doxorubicin?

Country	Value	Shipments	Share
NETHERLANDS	$654.8K	87	33.6%
BRAZIL	$369.8K	15	19.0%
POLAND	$289.1K	27	14.8%
UNITED KINGDOM	$141.8K	21	7.3%
SPAIN	$126.6K	18	6.5%

Who Are the Top Buyers of Doxorubicin from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	NETHERLANDS	$449.3K	92
ACCORD FARMACEUTICA LTDA	BRAZIL	$182.7K	10
ACCORD HEALTHCARE POLSKA SP. Z O.O.	POLAND	$181.5K	13
ACCORD UK	UNITED KINGDOM	$108.2K	13
BROCACEF NL HUB	NETHERLANDS	$87.2K	13
BROCACEF NL : HUB	NETHERLANDS	$77.2K	15
ACCORD HEALTHCARE C/O QESTMED	SOUTH AFRICA	$67.8K	3
ALLOGA FRANCE	FRANCE	$64.8K	7
ACCORD FARMACUTICA LIMITEDA.	BRAZIL	$56.1K	2
ACCORD HEALTHCARE INC	CANADA	$56.0K	3

Intas Pharmaceuticals Limited supplies Doxorubicin to 46 buyers globally. The largest buyer is TO THE ORDER (NETHERLANDS), followed by ACCORD FARMACEUTICA LTDA (BRAZIL) and ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Doxorubicin Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUG&MED: DOCKS DOXORUBICIN 2MG/ML 25ML1V(ACC-BRZ EACH ML CONTAINS: DOXORUBICIN HYDROCHLORIDE USP#..2 MG WATER FO	$115.1K	4
DOXORUBICIN ACC 200MG/100ML	$100.0K	2
PHARM DRUG&MED:DOXORUBICINE ACCORD 2 MG/ML 25ML EACH ML CONT DOXORUBICIN HYDROCHLORIDE PH.EUR 2MG WATER FOR I(ASPERINV)	$90.5K	3
PHARMA DRUG&MED:DOCKS DOXORUBICIN 2MG/ML	$81.1K	2
PHR DRUGS&MEDI DOXORUBICIN INJ,2MG/ML,25ML(ACCO-ROMANIA DETAILS AS PER INVOICE	$73.8K	4
PHARM DRUG MED DOXORUBICINE ACCORD 2 MG ML 25ML EACH ML CONTAINS DOXORUBICIN HYDROCHLORIDE PH EUR 2 MG ASPERINV	$57.3K	3
PHARMA DRUGS & MEDI DOCKS DOXORUBICIN 2MG/ML 25ML1V(ACC-BRZ AS PER INVOICE	$56.1K	2
PHR DRUGS&MEDI DOXORUBICIN ACCORD BP 50M	$52.1K	2
PHARMA DRUG&MED: DOCKS DOXORUBICIN 2MG/ML 25ML1VACC-BRZ Each mL contains: Doxorubicin Hydrochloride USP#..2 mg Water fo	$50.0K	1
DOXORUBICIN INJ. BP 2 MG/ML25 MLE2	$50.0K	1

Intas Pharmaceuticals Limited exports 293 distinct Doxorubicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUG&MED: DOCKS DOXORUBICIN 2MG/ML 25ML1V(ACC-BRZ EAC with 4 shipments worth $115.1K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Doxorubicin Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	FRESENIUS KABI ONCOLOGY LIMITED	$3.1M	143	18	$21.5K
2	DR.REDDY'S LABORATORIES LTD	$2.5M	51	11	$50.0K
6	INTAS PHARMACEUTICALS LIMITED ★	$1.8M	393	16	$4.6K
7	EUGIA PHARMA SPECIALITIES LIMITED	$1.4M	98	1	$14.7K
9	VENUS REMEDIES LIMITED	$1.1M	100	15	$11.0K

Intas Pharmaceuticals Limited ranks #6 among 310 Indian Doxorubicin exporters. Average shipment value of $4.6K compared to the market average of $70.4K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and DR.REDDY'S LABORATORIES LTD.

Which Indian Ports Ship Doxorubicin Exports?

Port	Shipments	% Share
SAHAR AIR	639	18.3%
SAHAR AIR CARGO ACC (INBOM4)	577	16.5%
DELHI AIR CARGO ACC (INDEL4)	464	13.3%
DELHI AIR	399	11.4%
Bombay Air	188	5.4%
AHEMDABAD AIR	150	4.3%
AHEMDABAD AIR ACC (INAMD4)	120	3.4%
Delhi Air	85	2.4%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Doxorubicin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Doxorubicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 414 individual customs records matching Intas Pharmaceuticals Limited exporting Doxorubicin, covering 293 formulations to 16 countries via 46 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 136+ countries, 899+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Doxorubicin

Doxorubicin

Intas Pharmaceuticals Limited — Doxorubicin Exporter Profile

Intas Pharmaceuticals Limited — Doxorubicin Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Doxorubicin?

Who Are the Top Buyers of Doxorubicin from Intas Pharmaceuticals Limited?

What Is India's Total Doxorubicin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Doxorubicin Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Doxorubicin Exporters?

What Doxorubicin Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Doxorubicin to Key Markets

Brazil — ANVISA

How Does Intas Pharmaceuticals Limited Compare to Nearest Doxorubicin Exporters?

Which Indian Ports Ship Doxorubicin Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Doxorubicin Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Doxorubicin Export Data from Intas Pharmaceuticals Limited

Doxorubicin Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source